C84.05
Mycosis fungoides, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Mycosis Fungoides is a type of skin lymphoma and a form of non-Hodgkin lymphoma that primarily affects the skin. When it involves the lymph nodes of the inguinal region (groin area) and lower limbs, it indicates a progression of the disease to deeper tissues. This condition typically develops slowly over years and often presents with peculiar skin changes, swelling, or lumps in affected areas. Recognizing this condition early is important for determining appropriate management strategies and monitoring disease progression.
Causes & Symptoms
Clinical Causes: Although the exact cause of Mycosis Fungoides is unknown, it is believed to originate from abnormal T-lymphocytes (a type of white blood cell). Genetic mutations may contribute to the malfunctioning and proliferation of these lymphocytes. Environmental factors, such as exposure to certain chemicals or viruses, have been explored but lack conclusive evidence. A family history of similar lymphoid or skin disorders might increase susceptibility, though it is not directly transmissible. Age is a relevant factor, as the disease most commonly affects middle-aged or older adults.
Key Symptoms: Persistent skin patches that may resemble eczema or psoriasis, often scaly or discolored. Itchy skin patches that do not respond to typical treatments. Development of skin plaques, which are thickened, raised areas on the skin. In advanced stages, lumps or tumors may appear on the skin. Swelling or enlarged lymph nodes in the groin (inguinal region) and sometimes in other areas. Possible ulceration or skin breakdown in affected regions. Over time, symptoms may involve more extensive skin areas or progress to blood, lymph nodes, and internal organs.
Diagnostic & Treatment
Diagnosis Path: To diagnose Mycosis Fungoides with lymph node involvement in the inguinal region and lower limbs, doctors may perform several tests, including: - Physical examination focusing on skin and lymph nodes. - Skin biopsies to examine tissue cells under a microscope. - Blood tests to assess overall health and detect abnormal lymphocytes. - Imaging studies such as ultrasound, CT scans, or PET scans to evaluate lymph node size and spread. - Lymph node biopsies if enlarged nodes are present. - Additional testing, like immunophenotyping, to determine specific cell types involved.
Treatment Protocols: Treatment options vary based on the stage and severity of the disease and may include: - Topical therapies such as corticosteroids, retinoids, or chemotherapy agents to control skin lesions. - Phototherapy (light-based therapy) to target abnormal lymphocytes. - Systemic treatments, including chemotherapy, targeted therapy, or immunotherapy, for advanced disease. - Radiation therapy for localized skin or lymph node lesions. - Biological agents to modulate the immune response. - Clinical trials exploring novel treatments may be suitable for some patients. - Regular follow-up is essential to monitor disease progression and response to therapy.
Clinical Advice & FAQs
Billing Guidance
Is C84.05 a billable ICD-10 code?
Yes, C84.05 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.05?
Clinical documentation must specify the nature of Mycosis fungoides, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference